EE59 Real-Life Costs of Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Treated by CAR T-Cells in France Between 2017 and 2020 (EpiCART Study)
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.331
https://www.valueinhealthjournal.com/article/S1098-3015(23)03461-7/fulltext
Title :
EE59 Real-Life Costs of Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Treated by CAR T-Cells in France Between 2017 and 2020 (EpiCART Study)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03461-7&doi=10.1016/j.jval.2023.09.331
First page :
Section Title :
Open access? :
No
Section Order :
12353